Menu

Kinross Gold Corporation (KGC)

$27.25
-0.09 (-0.31%)
Get curated updates for this stock by email. We filter for the most important fundamentals-focused developments and send only the key news to your inbox.

Data provided by IEX. Delayed 15 minutes.

Market Cap

$33.1B

Enterprise Value

$32.5B

P/E Ratio

18.8

Div Yield

0.52%

Rev Growth YoY

+21.4%

Rev 3Y CAGR

+25.6%

Earnings YoY

+127.9%

Earnings 3Y CAGR

+62.5%

Company Profile

At a glance

A Capital Allocation Inflection Point: Kinross Gold has completed a dramatic financial transformation, moving from a debt-laden balance sheet in 2023 to a net cash position of nearly $500 million by Q3 2025. This shift enables an unprecedented $1.5 billion in total capital returns in 2025—more than 50% above 2024 levels—through aggressive share buybacks ($600 million) and a 17% dividend increase, while simultaneously funding a robust project pipeline.

Operational Excellence at Scale: Despite maintaining a stable 2 million ounce annual production profile, Kinross generates industry-leading margins with Q3 2025 all-in sustaining costs of $1,145 per ounce against a $3,458 realized gold price, delivering margins exceeding $2,300 per ounce. Tasiast and Paracatu consistently rank among the lowest-cost gold mines globally, with Tasiast's 2024 cost of sales at just $681 per ounce, creating a durable competitive moat that competitors cannot easily replicate.

Project Pipeline as a Strategic Asset: The Great Bear project (first production 2029, 500k oz/year at $800 AISC) and Curlew (potential 100k oz/year from 2028) provide visible production growth without the execution risk and dilution of major M&A. This pipeline supports management's commitment to maintaining 2 million ounces through the end of the decade, insulating the company from the depletion challenges plaguing larger peers.

Price Chart

Loading chart...

The most compelling investment themes are the ones nobody is talking about yet.

Every Monday, get three under-the-radar themes with catalysts, data, and stocks poised to benefit.

Sign up now to receive them!

Also explore our analysis on 5,000+ stocks